Amicus Therapeutics

Amicus targets lysosomal storage disorders - ultra-rare genetic diseases affecting hundreds of patients globally. Like orchids evolved for specific pollinators, they specialize in tiny markets others ignore, enzyme replacement therapies too niche for mass production.